Results 101 to 110 of about 37,023 (237)

Mitochondria‑Targeted Galactose Nanodots for Ferroptosis‑Boosted Photodynamic Therapy of Hypoxic Liver Cancer

open access: yesAggregate, Volume 7, Issue 11, November 2026.
A glycocluster‐mediated nanoplatform efficiently enables hypoxia‐tolerant photodynamic therapy in HepG2 liver tumor models by triggering GPX4‐inhibited ferroptosis and disrupting redox homeostasis, offering a robust strategy to circumvent therapeutic resistance in solid tumors.
Jin Gong   +9 more
wiley   +1 more source

Real‐World Validation of the MAGIC‐D Index in Unresectable Biliary Tract Cancer Treated With Durvalumab Plus Chemotherapy

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
Real‐world Validation of the MAGIC‐D Index. The MAGIC‐D index was validated using real‐world data from patients with unresectable BTC who received durvalumab‐chemotherapy at Tongji Hospital. The risk stratification ability of the MAGIC‐D index for patient survival was improved after incorporating Ki67 and CA 19‐9.
Tianao Zhan   +9 more
wiley   +1 more source

Quality of Life Outcomes From the Phase 3 Study of Atezolizumab + Bevacizumab and Chemotherapy (ATTLAS, KCSG‐LU19‐04) in EGFR/ALK‐Mutated Non–Small‐Cell Lung Cancer

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Introduction The phase 3 ATTLAS study demonstrated that atezolizumab plus bevacizumab, carboplatin, and paclitaxel (ABCP) improved progression‐free survival compared with pemetrexed‐carboplatin/cisplatin (PC) in EGFR/ALK‐mutated non–small‐cell lung cancer after tyrosine kinase inhibitor failure. We report patient‐reported quality of life (QoL)
Eun Joo Kang   +23 more
wiley   +1 more source

Chemotherapy-Induced Nausea and Vomiting #285 [PDF]

open access: yesJournal of Palliative Medicine, 2014
Nishant, Tageja, Hunter, Groninger
openaire   +2 more sources

The Treatment Strategies for Intermediate‐Advanced Hepatocellular Carcinoma Based on Albumin–Bilirubin Grade: A Multicenter Retrospective Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background To evaluate whether the albumin–bilirubin (ALBI) grade modifies the association of combined locoregional plus systemic therapy versus systemic therapy alone with outcomes in unresectable hepatocellular carcinoma (HCC). Methods This multicente retrospective study enrolled 525 patients, stratified by the established ALBI grade cut‐off
Kang Liang   +9 more
wiley   +1 more source

Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients

open access: yes, 2011
Vicky TC Chan, Winnie YeoDepartment of Clinical Oncology, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, ChinaAbstract: Chemotherapy-induced nausea and vomiting (CINV) continues to be one of the most distressing side effects of ...
Chan VTC, Yeo W
core  

Eltrombopag during induction chemotherapy in older patients with newly diagnosed acute myeloid leukemia is safe and reduces platelet transfusion requirements: The EPAG‐2015 French Innovative Leukemia Organization phase 2 randomized trial

open access: yesCancer, Volume 132, Issue 21, 1 November 2026.
Abstract Background Elderly patients with acute myeloid leukemia (AML) treated with intensive chemotherapy are at risk of developing thrombopenia, which requires platelet transfusions. It would be interesting to provide them with thrombopoietin receptor agonists such as eltrombopag.
Arnaud Pigneux   +24 more
wiley   +1 more source

Translation and psychometric assessment of the Persian version of the Rhodes Index of Nausea, Vomiting and Retching (INVR) scale for the assessment of chemotherapy-induced nausea and vomiting

open access: yes, 2013
No tools are available to assess or measure the experience of chemotherapy-induced nausea and vomiting (CINV) for Persian/Farsi speakers. The purpose of this study is to translate the Rhodes Index of Nausea, Vomiting and Retching (INVR) scale for use ...
Molasiotis, A.   +11 more
core   +2 more sources

Ascites Presenting as a Peritonitis‐Like Manifestation and Liver Injury due to Trabectedin Monotherapy in a Patient With Myxoid Liposarcoma

open access: yesCancer Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background Trabectedin is a synthetic, marine‐derived antitumor agent that exerts cytotoxic effects by binding to the minor groove of DNA. While trabectedin has demonstrated efficacy in advanced soft tissue sarcomas, hepatotoxicity and other adverse events remain concerns.
Tatsuyuki Kawahara   +11 more
wiley   +1 more source

Olanzapine in Chemotherapy Induced Nausea and Vomiting

open access: yes, 2021
: Objective: Patients diagnosed with cancer and undergoing chemotherapeutic regimen often anticipate many negative effects of the therapy. Chemotherapy induced nausea and vomiting is of their principal concerns which remains one of the most unpleasant ...
Hussain, Syed Saad   +2 more
core  

Home - About - Disclaimer - Privacy